SEPS.F Stock Overview
Focuses on developing diagnostic and therapeutic solutions for the treatment of sepsis. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
ASEP Medical Holdings Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.028 |
| 52 Week High | CA$0.15 |
| 52 Week Low | CA$0.028 |
| Beta | -2.27 |
| 1 Month Change | -30.75% |
| 3 Month Change | n/a |
| 1 Year Change | -84.32% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -90.11% |
Recent News & Updates
Recent updates
Shareholder Returns
| SEPS.F | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 0% | 2.7% | 2.8% |
| 1Y | -84.3% | 10.6% | 24.6% |
Return vs Industry: SEPS.F underperformed the US Medical Equipment industry which returned 10.6% over the past year.
Return vs Market: SEPS.F underperformed the US Market which returned 24.6% over the past year.
Price Volatility
| SEPS.F volatility | |
|---|---|
| SEPS.F Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 7.9% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 17.4% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: SEPS.F's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine SEPS.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2021 | 6 | Robert E. Hancock | asepmedical.com |
ASEP Medical Holdings Inc., together with its subsidiaries, focuses on developing diagnostic and therapeutic solutions for the treatment of sepsis. It offers peptide technology for therapeutic applications, including bacterial biofilm infections, anti-inflammatories, anti-infective immune-modulators, and vaccine adjuvants; diagnostic kits for predicting the onset of severe sepsis and organ failure; and coatings for medical devices. The company was formerly known as Trenchant Life Sciences Investment Corp. and changed its name to ASEP Medical Holdings Inc. in November 2021.
ASEP Medical Holdings Inc. Fundamentals Summary
| SEPS.F fundamental statistics | |
|---|---|
| Market cap | US$2.94m |
| Earnings (TTM) | -US$3.22m |
| Revenue (TTM) | US$169.50k |
17.3x
P/S Ratio-0.9x
P/E RatioIs SEPS.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SEPS.F income statement (TTM) | |
|---|---|
| Revenue | CA$243.92k |
| Cost of Revenue | CA$0 |
| Gross Profit | CA$243.92k |
| Other Expenses | CA$4.88m |
| Earnings | -CA$4.64m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.06 |
| Gross Margin | 100.00% |
| Net Profit Margin | -1,900.29% |
| Debt/Equity Ratio | 1.5% |
How did SEPS.F perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/27 16:34 |
| End of Day Share Price | 2024/12/18 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
ASEP Medical Holdings Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|